|
1
|
Engel T and Henshall DC: Apoptosis, Bcl-2
family proteins and caspases: The ABCs of seizure-damage and
epileptogenesis? Int J Physiol Pathophysiol Pharmacol. 1:97–115.
2009.PubMed/NCBI
|
|
2
|
Cai Z, Li S, Li S, Song F, Zhang Z, Qi G,
Li T, Qiu J, Wan J, Sui H and Guo H: Antagonist targeting
microRNA-155 protects against lithium-pilocarpine-induced status
epilepticus in C57BL/6 mice by activating brain-derived
neurotrophic factor. Front Pharmacol. 7:1292016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang H, Zhou H and Wang N: Recent
advances in epilepsy management. Cell Biochem Biophys. 73:7–10.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Omran A, Peng J, Zhang C, Xiang QL, Xue J,
Gan N, Kong H and Yin F: Interleukin-1β and microRNA-146a in an
immature rat model and children with mesial temporal lobe epilepsy.
Epilepsia. 53:1215–1224. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stephen LJ, Kelly K, Mohanraj R and Brodie
MJ: Pharmacological outcomes in older people with newly diagnosed
epilepsy. Epilepsy Behav. 8:434–437. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li MM, Li XM, Zheng XP, Yu JT and Tan L:
MicroRNAs dysregulation in epilepsy. Brain Res. 1584:94–104. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aronica E, Fluiter K, Iyer A, Zurolo E,
Vreijling J, van Vliet EA, Baayen JC and Gorter JA: Expression
pattern of miR-146a, an inflammation-associated microRNA, in
experimental and human temporal lobe epilepsy. Eur J Neurosci.
31:1100–1107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Gibson G, Kim JS, Kroin J, Xu S, van
Wijnen AJ and Im HJ: MicroRNA-146a is linked to pain-related
pathophysiology of osteoarthritis. Gene. 480:34–41. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miller JA, Kirkley KA, Padmanabhan R,
Liang LP, Raol YH, Patel M, Bialecki RA and Tjalkens RB: Repeated
exposure to low doses of kainic acid activates nuclear factor kappa
B (NF-κB) prior to seizure in transgenic NF-κB/EGFP reporter mice.
Neurotoxicology. 44:39–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang Y and Wang X: Developing a new
perspective to study the health of survivors of Sichuan earthquakes
in China: A study on the effect of post-earthquake rescue policies
on survivors' health-related quality of life. Health Res Policy
Syst. 11:412013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang Y and Lu P: Effect of occupational
mobility and health status on life satisfaction of Chinese
residents of different occupations: Logistic diagonal mobility
models analysis of cross-sectional data on eight Chinese provinces.
Int J Equity Health. 13:152014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lubin FD, Ren Y, Xu X and Anderson AE:
Nuclear factor-kappa B regulates seizure threshold and gene
transcription following convulsant stimulation. J Neurochem.
103:1381–1395. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vezzani A, Friedman A and Dingledine RJ:
The role of inflammation in epileptogenesis. Neuropharmacology.
69:16–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rowley S and Patel M: Mitochondrial
involvement and oxidative stress in temporal lobe epilepsy. Free
Radical Biol Med. 62:121–131. 2013. View Article : Google Scholar
|
|
16
|
Meffert MK and Baltimore D: Physiological
functions for brain NF-kappaB. Trends Neurosci. 28:37–43. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
da Costa AV, Calábria LK, Nascimento R,
Carvalho WJ, Goulart LR and Espindola FS: The
streptozotocin-induced rat model of diabetes mellitus evidences
significant reduction of myosin-Va expression in the brain. Metab
Brain Dis. 26:247–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ravizza T, Rizzi M, Perego C, Richichi C,
Velísková J, Moshé SL, De Simoni MG and Vezzani A: Inflammatory
response and glia activation in developing rat hippocampus after
status epilepticus. Epilepsia. 46 Suppl 5:113–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patterson KP, Brennan GP, Curran M,
Kinney-Lang E, Dubé C, Rashid F, Ly C, Obenaus A and Baram TZ:
Rapid, coordinate inflammatory responses after experimental febrile
status epilepticus: Implications for epileptogenesis. eNeuro.
2:0034–15. 2015. View Article : Google Scholar
|
|
20
|
Itoh K, Ishihara Y, Komori R, Nochi H,
Taniguchi R, Chiba Y, Ueno M, Takata-Tsuji F, Dohgu S and Kataoka
Y: Levetiracetam treatment influences blood-brain barrier failure
associated with angiogenesis and inflammatory responses in the
acute phase of epileptogenesis in post-status epilepticus mice.
Brain Res. 1652:1–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Faraoni I, Antonetti FR, Cardone J and
Bonmassar E: miR-155 gene: A typical multifunctional microRNA.
Biochim Biophys Acta. 1792:497–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aronica E, van Vliet EA, Hendriksen E,
Troost D, Lopes da Silva FH and Gorter JA: Cystatin Ca cysteine
protease inhibitor, is persistently up-regulated in neurons and
glia in a rat model for mesial temporal lobe epilepsy. Eur J
Neurosci. 14:1485–1491. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu K, Zhang C, Long L, Long X, Feng L, Li
Y and Xiao B: Expression profile of microRNAs in rat hippocampus
following lithium-pilocarpine-induced status epilepticus. Neurosci
Lett. 488:252–257. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mattson MP and Camandola S: NF-kappaB in
neuronal plasticity and neurodegenerative disorders. J Clin Invest.
107:247–254. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mattson MP and Meffert MK: Roles for
NF-kappaB in nerve cell survival, plasticity, and disease. Cell
Death Differ. 13:852–860. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu Z, Zhou D, Cheng G and Mattson MP:
Neuroprotective role for the p50 subunit of NF-kappaB in an
experimental model of Huntington's disease. J Mol Neurosci.
15:31–44. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu N, Di Q, Liu H, Hu Y, Jiang Y, Yan YK,
Zhang YF and Zhang YD: Nuclear factor-kappa B activity regulates
brain expression of P-glycoprotein in the kainic acid-induced
seizure rats. Mediat Inflamm. 2011:6706132011. View Article : Google Scholar
|
|
28
|
Zhang J, Zhang M, Sun B, Li Y, Xu P, Liu
C, Liu L and Liu X: Hyperammonemia enhances the function and
expression of P-glycoprotein and Mrp2 at the blood-brain barrier
through NF-κB. J Neurochem. 131:791–802. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lazarowski A, Czornyj L, Lubienieki F,
Girardi E, Vazquez S and D'Giano C: ABC transporters during
epilepsy and mechanisms underlying multidrug resistance in
refractory epilepsy. Epilepsia. 48 Suppl 5:S140–S149. 2007.
View Article : Google Scholar
|
|
30
|
Volk H, Potschka H and Löscher W:
Immunohistochemical localization of P-glycoprotein in rat brain and
detection of its increased expression by seizures are sensitive to
fixation and staining variables. J Histochem Cytochem. 53:517–531.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thom M, Zhou JM, Martinian L and Sisodiya
S: Quantitative post-mortem study of the hippocampus in chronic
epilepsy: Seizures do not inecvitably cause neuronal loss. Brain.
128:1344–1357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kondratyev A and Gale K: Intracerebral
injection of caspase-3 inhibitor prevents neuronal apoptosis after
kainic acid-evoked status epilepticus. Brain Res Mol Brain Res.
75:2216–224. 2000. View Article : Google Scholar
|
|
33
|
Heath-Engel HM, Chang NC and Shore GC: The
endoplasmic reticulum in apoptosis and autophagy: Role of the BCL-2
protein family. Oncogene. 27:6419–6433. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sanchez A, Tripathy D, Yin X, Luo J,
Martinez J and Grammas P: Pigment epithelium-derived factor (PEDF)
protects cortical neurons in vitro from oxidant injury by
activation of extracellular signal-regulated kinase (ERK) 1/2 and
induction of Bcl-2. Neurosci Res. 72:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zeren T, Inan S, Vatansever HS and Sayhan
S: Significance of apoptosis related proteins on malignant
transformation of ovarian tumors: A comparison between Bcl-1/Bax
ratio and p53 immunoreactivity. Acta Histochem. 116:1251–1258.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vezzani A and Granata T: Brain
inflammation in epilepsy: Experimental and clinical evidence.
Epilepsia. 46:1724–1743. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vezzani A and Baram TZ: New roles for
interleukin-1 Beta in the mechanisms of epilepsy. Epilepsy Curr.
7:45–50. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peltola J, Palmio J, Korhonen L, Suhonen
J, Miettinen A, Hurme M, Lindholm D and Keränen T: Interleukin-6
and interleukin-1 receptor antagonist in cerebrospinal fluid from
patients with recent tonic-clonic seizures. Epilepsy Res.
41:205–211. 2000. View Article : Google Scholar : PubMed/NCBI
|
